SCHEMBL23699259

SCHEMBL23699259

CNCC(C(=O)N1CCC(c2ccc(F)cc2)(N(C)C)CC1)C(C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.44
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
OPRM1 P35372 11/20 0.38
OPRL1 P41146 11/20 0.38
AGTR2 P50052 1/20 0.37
SLC6A3 Q01959 1/20 0.37
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23699257 1.00 CCR1 (0.44) CCR1SLC6A2SLC6A4OPRM1OPRL1
SCHEMBL23699228 0.93 OPRM1 (0.44) SLC6A2SLC6A4OPRM1OPRL1SLC6A3
SCHEMBL23719123 0.93 OPRM1 (0.44) SLC6A2SLC6A4OPRM1OPRL1SLC6A3
SCHEMBL23699229 0.93 OPRM1 (0.44) SLC6A2SLC6A4OPRM1OPRL1SLC6A3
SCHEMBL23719110 0.93 OPRM1 (0.44) SLC6A2SLC6A4OPRM1OPRL1SLC6A3
SCHEMBL23699319 0.93 OPRM1 (0.44) SLC6A2SLC6A4OPRM1OPRL1SLC6A3
SCHEMBL23699243 0.93 OPRM1 (0.44) SLC6A2SLC6A4OPRM1OPRL1SLC6A3
Hydrochloric Acid SCHEMBL23699211 0.92 OPRM1 (0.44) SLC6A2SLC6A4OPRM1OPRL1SLC6A3
Hydrochloric Acid SCHEMBL23699209 0.92 OPRM1 (0.44) SLC6A2SLC6A4OPRM1OPRL1SLC6A3
SCHEMBL23699395 0.89 OPRM1 (0.44) CCR1SLC6A2SLC6A4OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP claimed
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP disclosed